Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease
Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbati...
Gespeichert in:
Veröffentlicht in: | Postgraduate medical journal 2009-03, Vol.85 (1001), p.141-147 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 147 |
---|---|
container_issue | 1001 |
container_start_page | 141 |
container_title | Postgraduate medical journal |
container_volume | 85 |
creator | Black, P N McDonald, C F |
description | Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study. |
doi_str_mv | 10.1136/pgmj.2008.072439 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67110301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4026196091</sourcerecordid><originalsourceid>FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</originalsourceid><addsrcrecordid>eNqFkE1r3DAQhkVpaTbb3nsKgtJcgreSJUv2MSzNB4RtD22uQpZHiTe2tJHkkPz7avGSQC89Dcw8M7zzIPSFkhWlTHzf3Y3bVUlIvSKy5Kx5hxaUi6YgshLv0YIQVhYVl-wIHce4JYQyyelHdEQbVlHB6QKpa5cgPIFLvXcRJ48DdJMBnO4B2wCPEzjzgr3F8KwNhFbPYG6Y--Bdb7BvYwqTSf0T4N00jN7p8IK7PoKO8Al9sHqI8PlQl-jPxY_f66vi5ufl9fr8pmh52aSClwKkAFG3TJBacq3rrq6oZLyxUuZquZWUQyO7CnKPQ36mllVjbNkZC2yJTue7u-Bz5pjU2EcDw6Ad-CkqISklLAtYoq__gFs_BZezKSrrLIVTITJFZsoEH2MAq3ahH_NfihK1V6_26tVevZrV55WTw-GpHaF7Wzi4zsC3A6Cj0YMN2pk-vnIlZbzijGeumLk-Jnh-nevwkL9gslKb27W63fwSZHNVqn3Ws5lvc6L_xvwL6cepXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781644166</pqid></control><display><type>article</type><title>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Black, P N ; McDonald, C F</creator><creatorcontrib>Black, P N ; McDonald, C F</creatorcontrib><description>Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.</description><identifier>ISSN: 0032-5473</identifier><identifier>EISSN: 1469-0756</identifier><identifier>DOI: 10.1136/pgmj.2008.072439</identifier><identifier>PMID: 19351641</identifier><language>eng</language><publisher>London: The Fellowship of Postgraduate Medicine</publisher><subject>Acute Disease ; Administration, Inhalation ; Adrenal Cortex Hormones - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacteria ; Biological and medical sciences ; Bronchodilator Agents - therapeutic use ; chronic airways disease ; Chronic obstructive pulmonary disease ; emphysema ; Expectorants - therapeutic use ; General aspects ; Health care expenditures ; Hospitalization ; Hospitals ; Humans ; long-acting inhaled β agonists ; Medical sciences ; Patient admissions ; Phosphodiesterase Inhibitors - therapeutic use ; Pneumonia ; Pulmonary Disease, Chronic Obstructive - drug therapy ; respiratory infections ; Scopolamine Derivatives - therapeutic use ; Steroids ; thoracic medicine ; Tiotropium Bromide ; Vaccination - methods</subject><ispartof>Postgraduate medical journal, 2009-03, Vol.85 (1001), p.141-147</ispartof><rights>2009 The Fellowship of Postgraduate Medicine</rights><rights>2009 INIST-CNRS</rights><rights>Copyright: 2009 2009 The Fellowship of Postgraduate Medicine</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</citedby><cites>FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pmj.bmj.com/content/85/1001/141.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://pmj.bmj.com/content/85/1001/141.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3182,23551,27903,27904,77346,77377</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21345434$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19351641$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Black, P N</creatorcontrib><creatorcontrib>McDonald, C F</creatorcontrib><title>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</title><title>Postgraduate medical journal</title><addtitle>Postgrad Med J</addtitle><description>Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.</description><subject>Acute Disease</subject><subject>Administration, Inhalation</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Biological and medical sciences</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>chronic airways disease</subject><subject>Chronic obstructive pulmonary disease</subject><subject>emphysema</subject><subject>Expectorants - therapeutic use</subject><subject>General aspects</subject><subject>Health care expenditures</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>long-acting inhaled β agonists</subject><subject>Medical sciences</subject><subject>Patient admissions</subject><subject>Phosphodiesterase Inhibitors - therapeutic use</subject><subject>Pneumonia</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>respiratory infections</subject><subject>Scopolamine Derivatives - therapeutic use</subject><subject>Steroids</subject><subject>thoracic medicine</subject><subject>Tiotropium Bromide</subject><subject>Vaccination - methods</subject><issn>0032-5473</issn><issn>1469-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkE1r3DAQhkVpaTbb3nsKgtJcgreSJUv2MSzNB4RtD22uQpZHiTe2tJHkkPz7avGSQC89Dcw8M7zzIPSFkhWlTHzf3Y3bVUlIvSKy5Kx5hxaUi6YgshLv0YIQVhYVl-wIHce4JYQyyelHdEQbVlHB6QKpa5cgPIFLvXcRJ48DdJMBnO4B2wCPEzjzgr3F8KwNhFbPYG6Y--Bdb7BvYwqTSf0T4N00jN7p8IK7PoKO8Al9sHqI8PlQl-jPxY_f66vi5ufl9fr8pmh52aSClwKkAFG3TJBacq3rrq6oZLyxUuZquZWUQyO7CnKPQ36mllVjbNkZC2yJTue7u-Bz5pjU2EcDw6Ad-CkqISklLAtYoq__gFs_BZezKSrrLIVTITJFZsoEH2MAq3ahH_NfihK1V6_26tVevZrV55WTw-GpHaF7Wzi4zsC3A6Cj0YMN2pk-vnIlZbzijGeumLk-Jnh-nevwkL9gslKb27W63fwSZHNVqn3Ws5lvc6L_xvwL6cepXg</recordid><startdate>20090301</startdate><enddate>20090301</enddate><creator>Black, P N</creator><creator>McDonald, C F</creator><general>The Fellowship of Postgraduate Medicine</general><general>BMJ Publishing Group</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20090301</creationdate><title>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</title><author>Black, P N ; McDonald, C F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acute Disease</topic><topic>Administration, Inhalation</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Biological and medical sciences</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>chronic airways disease</topic><topic>Chronic obstructive pulmonary disease</topic><topic>emphysema</topic><topic>Expectorants - therapeutic use</topic><topic>General aspects</topic><topic>Health care expenditures</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>long-acting inhaled β agonists</topic><topic>Medical sciences</topic><topic>Patient admissions</topic><topic>Phosphodiesterase Inhibitors - therapeutic use</topic><topic>Pneumonia</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>respiratory infections</topic><topic>Scopolamine Derivatives - therapeutic use</topic><topic>Steroids</topic><topic>thoracic medicine</topic><topic>Tiotropium Bromide</topic><topic>Vaccination - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Black, P N</creatorcontrib><creatorcontrib>McDonald, C F</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Postgraduate medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Black, P N</au><au>McDonald, C F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</atitle><jtitle>Postgraduate medical journal</jtitle><addtitle>Postgrad Med J</addtitle><date>2009-03-01</date><risdate>2009</risdate><volume>85</volume><issue>1001</issue><spage>141</spage><epage>147</epage><pages>141-147</pages><issn>0032-5473</issn><eissn>1469-0756</eissn><abstract>Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.</abstract><cop>London</cop><pub>The Fellowship of Postgraduate Medicine</pub><pmid>19351641</pmid><doi>10.1136/pgmj.2008.072439</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0032-5473 |
ispartof | Postgraduate medical journal, 2009-03, Vol.85 (1001), p.141-147 |
issn | 0032-5473 1469-0756 |
language | eng |
recordid | cdi_proquest_miscellaneous_67110301 |
source | MEDLINE; BMJ Journals - NESLi2; Oxford University Press Journals All Titles (1996-Current) |
subjects | Acute Disease Administration, Inhalation Adrenal Cortex Hormones - therapeutic use Anti-Bacterial Agents - therapeutic use Antibiotics Bacteria Biological and medical sciences Bronchodilator Agents - therapeutic use chronic airways disease Chronic obstructive pulmonary disease emphysema Expectorants - therapeutic use General aspects Health care expenditures Hospitalization Hospitals Humans long-acting inhaled β agonists Medical sciences Patient admissions Phosphodiesterase Inhibitors - therapeutic use Pneumonia Pulmonary Disease, Chronic Obstructive - drug therapy respiratory infections Scopolamine Derivatives - therapeutic use Steroids thoracic medicine Tiotropium Bromide Vaccination - methods |
title | Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T14%3A53%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventions%20to%20reduce%20the%20frequency%20of%20exacerbations%20of%20chronic%20obstructive%20pulmonary%20disease&rft.jtitle=Postgraduate%20medical%20journal&rft.au=Black,%20P%20N&rft.date=2009-03-01&rft.volume=85&rft.issue=1001&rft.spage=141&rft.epage=147&rft.pages=141-147&rft.issn=0032-5473&rft.eissn=1469-0756&rft_id=info:doi/10.1136/pgmj.2008.072439&rft_dat=%3Cproquest_cross%3E4026196091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781644166&rft_id=info:pmid/19351641&rfr_iscdi=true |